Pfizer Takes Kidney Cancer Drug Overseas

Fox Business , Wednesday, September 5, 2012 10:45 AM
  • Comment
  • Recommend
Subscribe to Around the Net In Brand Marketing

Tags

Pfizer Inc. has received marketing authorization from the European Commission for its kidney cancer drug, Inlyta, meant to treat adults with an advanced type of kidney cancer.

Read the whole story at Fox Business »
  • Comment
  • Recommend

Be the first to comment on "Pfizer Takes Kidney Cancer Drug Overseas "

Leave a Comment

Sign in to leave a comment. Don't have an account? Join Now

Recent Around the Net In Brand Marketing Articles

>> Around the Net In Brand Marketing Archives